A genetic variant in microRNA-146a is associated with sporadic breast cancer in a Southern Brazilian Population

• Autor(a) principal: Brincas,Heloisa Magagnin
• Data de Publicação: 2019
• Outros Autores: Augusto,Danillo G., Mathias,Carolina, Cavalli,Iglenir João, Lima,Rubens Silveira de, Kuroda,Flávia, Urban,Cícero de Andrade, Gradia,Daniela Fiori, de Oliveira,Jaqueline, de Almeida,Rodrigo Coutinho, Ribeiro,Enilze Maria de Souza Fonseca
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Genetics and Molecular Biology
• Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572019000500103
• topic: miRNA polymorphism; miR146a; rs2910164; Breast cancer; Case-control study

Abstract MicroRNAs (miRNAs) play an essential role in gene expression and affect the development of tumours, including breast cancer (BC). Polymorphisms in miRNA genes can affect the interaction of miRNAs with their target messenger RNA by interfering, creating or disrupting target sites. The single nucleotide polymorphism (SNP) rs2910164, located in the seed region of miR146a, was shown to be associated with BC among different populations. In the present study, we investigated whether rs2910164 is associated with BC in 326 patients and 411 controls from a Brazilian population of predominantly European ancestry. The presence of the allele rs2910164*C was associated with an increased risk of BC (OR=1.4, 95% CI=1.03-1.85, p = 0.03). We also analysed publicly available RNA-seq data to evaluate if miR146a is differentially expressed in different subtypes of BC. Genotyping was performed by polymerase chain reaction with sequence-specific primers (PCR-SSP). By leveraging public data from TCGA database, we analysed 461 patients and found that miR146a is significantly more expressed in BC than in non-tumor tissue (1.47 fold, p = 0.02) and is expressed to a greater degree in aggressive BC subtypes.